Daymark Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.82M Sell
81,618
-852
-1% -$98.4K 0.31% 63
2025
Q4
$8.68M Sell
82,470
-675
-0.8% -$63.4K 0.28% 70
2025
Q3
$6.98M Sell
83,145
-1,842
-2% -$152K 0.24% 86
2025
Q2
$6.73M Sell
84,987
-4,002
-4% -$318K 0.26% 84
2025
Q1
$8.06M Sell
88,989
-134,066
-60% -$12.5M 0.35% 65
2024
Q4
$10.4M Buy
223,055
+1,236
+0.6% +$127K 0.44% 48
2024
Q3
$11.7M Buy
221,819
+673
+0.3% +$80K 0.49% 47
2024
Q2
$12.6M Buy
221,146
+9,566
+5% +$1.23M 0.58% 40
2024
Q1
$12.2M Buy
211,580
+793
+0.4% +$97.7K 0.66% 39
2023
Q4
$10M Buy
210,787
+5,414
+3% +$562K 0.62% 39
2023
Q3
$8.91M Buy
205,373
+121,079
+144% +$13.1M 0.61% 41
2023
Q2
$9.73M Buy
84,294
+22,052
+35% +$2.5M 0.72% 39
2023
Q1
$6.62M Buy
62,242
+12,177
+24% +$1.31M 0.88% 24
2022
Q4
$5.55M Buy
+50,065
New +$5.12M 0.98% 25

Other funds holding MRK

Daymark Wealth Partners's MRK Position: Q1 2026 in Review

Daymark Wealth Partners reduced its Merck (MRK) stake by 1% in Q1 2026, selling an estimated $98.4K and leaving 81,618 shares worth $9.82M. The position accounts for 0.31% of the portfolio, ranked #63.

Daymark Wealth Partners first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $12.6M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Daymark Wealth Partners held 81,618 shares of Merck worth $9.82M as of Q1 2026.
  • Daymark Wealth Partners sold 852 Merck shares in Q1 2026, an estimated $98.4K.
  • Merck made up 0.31% of Daymark Wealth Partners's portfolio in Q1 2026, its #63 holding.
  • Daymark Wealth Partners first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Daymark Wealth Partners's Merck position peaked at $12.6M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.